Skip to main content

Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial Hypertension

Ventavis is an inhaled formulation of iloprost, a prostacyclin analog, indicated for the treatment of pulmonary arterial hypertension (PAH) in patients with NYHA Class III or IV symptoms.

Related articles

Ventavis (iloprost) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.